Kurzporträt
Mitarbeiterzahl: 101
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Jesse Ledger
CEO | Chief Executive Officer | - | 06.04.16 |
Director of Finance/CFO | - | 01.01.12 | |
Bernard Chiasson
COO | Chief Operating Officer | - | - |
Wade Hull
CTO | Chief Tech/Sci/R&D Officer | - | - |
John London
BRD | Director/Board Member | - | - |
Corporate Officer/Principal | - | 01.01.19 | |
Cally Lunetta
PRN | Corporate Officer/Principal | - | - |
Katina Loucaides
LAW | General Counsel | - | 01.01.08 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Rob Harris
CHM | Chairman | 69 | 05.04.17 |
Director/Board Member | - | 21.09.04 | |
John London
BRD | Director/Board Member | - | - |
Mary Ritchie
BRD | Director/Board Member | 67 | 17.05.21 |
Anthony Y. Snow
BRD | Director/Board Member | 49 | 12.08.22 |
Director/Board Member | 68 | 16.05.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 11 388 000 | 10 851 712 ( 95,29 %) | 0 | 95,29 % |
Unternehmenskontakt
Nuvo Pharmaceuticals, Inc.
6733 Mississauga Road Suite 800
L5N 6J5, Mississauga
+
http://www.miravohealthcare.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+25,83 % | 661 Mrd. | |
+27,00 % | 566 Mrd. | |
-6,76 % | 352 Mrd. | |
+20,34 % | 332 Mrd. | |
+3,00 % | 283 Mrd. | |
+13,09 % | 231 Mrd. | |
+5,46 % | 200 Mrd. | |
-9,61 % | 195 Mrd. | |
-6,26 % | 145 Mrd. |